UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

____________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act Of 1934

August 1, 2014

Date of Report (Date of earliest event reported)

___________________________________________________________

CADISTA HOLDINGS INC.

(Exact Name of Registrant as Specified in Charter)

___________________________________________________________

State of Delaware	000-54421	31-1259887
(State of Other Jurisdiction	(Commission File Number)	(I.R.S. Employer
of Incorporation)		Identification Number)

207 Kiley Drive

Salisbury, MD 21801

(Address of principal executive offices) (Zip Code)

(410) 912-3700

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e- 4(c))

Item 5.02 Departure of Directors or Certain Officers, Election of Directors,

Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b)

By letter, dated August 1, 2014, Mr. Neeraj Agrawal resigned as a member of our Board of Directors, and as a member of the Board of Directors of our wholly-owned subsidiary, Jubilant Cadista Pharmaceuticals Inc., in each case effective immediately following the Board of Directors meetings held on such date.

In conjunction with Mr. Agrawal’s resignation, our Board of Directors, by resolution, reduced the number of directors constituting our whole Board of Directors from six to five directors.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CADISTA HOLDINGS INC.


	By:	/s/ Kamal Mandan
		Kamal Mandan
		Chief Financial Officer

Date: August 4, 2014

Cadista Holdings Inc. 8-K